These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15881352)

  • 1. [Loss of IGF2 imprinting in colorectal cancer].
    Wang Y; Li GW; Wen BG
    Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):71-3. PubMed ID: 15881352
    [No Abstract]   [Full Text] [Related]  

  • 2. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
    Zhang FR; He XB; Yang YH; Xie W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection.
    Maenaka S; Hikichi T; Imai MA; Minamoto T; Kawahara E
    Oncol Rep; 2006 Apr; 15(4):791-5. PubMed ID: 16525660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer.
    Takano Y; Shiota G; Kawasaki H
    Oncology; 2000 Sep; 59(3):210-6. PubMed ID: 11053988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
    Li H; Zhang N
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The imprinting status and expression of insulin-like growth factor 2 gene in human hepatocellular carcinoma].
    He WZ; Qin Y; Li B; Liu JY; Sun ZL; Sun ZF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):466-9. PubMed ID: 15291100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotreme IGF2 expression and ancestral origin of genomic imprinting.
    Killian JK; Nolan CM; Stewart N; Munday BL; Andersen NA; Nicol S; Jirtle RL
    J Exp Zool; 2001 Aug; 291(2):205-12. PubMed ID: 11479919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk.
    Cui H; Cruz-Correa M; Giardiello FM; Hutcheon DF; Kafonek DR; Brandenburg S; Wu Y; He X; Powe NR; Feinberg AP
    Science; 2003 Mar; 299(5613):1753-5. PubMed ID: 12637750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxation of imprinting of the insulin-like growth factor II gene in colorectal cancer.
    Kinouchi Y; Hiwatashi N; Higashioka S; Nagashima F; Chida M; Toyota T
    Cancer Lett; 1996 Oct; 107(1):105-8. PubMed ID: 8913273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imprinting and colorectal cancer.
    Miyaki M
    Nat Med; 1998 Nov; 4(11):1236-7. PubMed ID: 9809540
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting.
    Harper J; Burns JL; Foulstone EJ; Pignatelli M; Zaina S; Hassan AB
    Cancer Res; 2006 Feb; 66(4):1940-8. PubMed ID: 16488992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
    Watanabe N; Nakadate H; Haruta M; Sugawara W; Sasaki F; Tsunematsu Y; Kikuta A; Fukuzawa M; Okita H; Hata J; Soejima H; Kaneko Y
    Genes Chromosomes Cancer; 2006 Jun; 45(6):592-601. PubMed ID: 16518847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk.
    Kaneda A; Feinberg AP
    Cancer Res; 2005 Dec; 65(24):11236-40. PubMed ID: 16357124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-II imprinting in cancer.
    Reeve AE; Becroft DM; Morison IM; Fukuzawa R
    Lancet; 2002 Jun; 359(9323):2050-1. PubMed ID: 12086755
    [No Abstract]   [Full Text] [Related]  

  • 15. IGF2 is parentally imprinted in human preimplantation embryos.
    Lighten AD; Hardy K; Winston RM; Moore GE
    Nat Genet; 1997 Feb; 15(2):122-3. PubMed ID: 9020833
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer. Developing molecular biomarkers for cancer.
    Ransohoff DF
    Science; 2003 Mar; 299(5613):1679-80. PubMed ID: 12637728
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
    Brown KW; Power F; Moore B; Charles AK; Malik KT
    Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
    Li Y; Meng G; Huang L; Guo QN
    Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs.
    Nezer C; Moreau L; Brouwers B; Coppieters W; Detilleux J; Hanset R; Karim L; Kvasz A; Leroy P; Georges M
    Nat Genet; 1999 Feb; 21(2):155-6. PubMed ID: 9988262
    [No Abstract]   [Full Text] [Related]  

  • 20. Loss of imprinting and promoter usage of the IGF2 in laryngeal squamous cell carcinoma.
    Grbesa I; Ivkic M; Pegan B; Gall-Troselj K
    Cancer Lett; 2006 Jul; 238(2):224-9. PubMed ID: 16111804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.